Demand For Immunity Boosters Lifts Nestlé Health Science
Executive Summary
Nestlé Health Science saw sales rise double digits in 2020 thanks to higher demand for health and immunity products during the pandemic.
You may also be interested in...
Nestle Pairs Nutrition Science Business With Pharma Firm Making Peanut Allergy Treatment
Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.
Nestle Acquires IM HealthScience, Expands Medical Food Lineup In Latest US Consumer Move
Nestle Health Science acquires IM HealthScience, marketer of medical foods IBgard and FDgard as well as prebiotic and sleep aid supplements. The deal is second recent US consumer health addition for the firm after it said 2020 would be “‘more vigorous” year for acquisitions despite the COVID-19 pandemic.
Vital Proteins’ ‘Timely’ Immunity Product Launch Makes Time Right For Nestle Investment
Nestle Health Science has majority stake in US firm that started offering a powder blend for beverages containing vitamin C, collagen, L glutamine, zinc, electrolytes and beta glucan earlier in 2020, when consumer interest spiked in boosting immunity health.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: